Clivarin and other LMWHs in an ex vivo cardiopulmonary bypass model. Studies on contact activation.
A large number of low-molecular-weight heparin (LMWH) preparations are contending for superiority and their pharmacological properties need to be assessed. Thus experimental and clinical experience accumulated from one LMWH can only be extrapolated to a limited extent to another LMWH.